Revolutionizing Cancer Treatment with Mechanosensitization
Join Us in the Fight Against Cancer
Discover how OncoMechanics, LLC is transforming cancer therapy by enhancing the effectiveness of immunotherapies through innovative biophysics-based strategies.
Pioneering Oncology Innovations
OncoMechanics, LLC is at the forefront of oncology innovation, dedicated to advancing cancer treatment through a unique mechanosensitization approach. Our mission is to improve patient outcomes by making tumors more susceptible to existing immunotherapies. We focus on triple-negative breast cancer (TNBC) and aim to expedite the development process by repurposing clinically approved small-molecule drugs, reducing both time and risk.
Understanding Mechanosensitization
Mechanosensitization is a groundbreaking strategy that enhances the effectiveness of immunotherapies by increasing the tension and stiffness of tumor-cell membranes. This mechanical priming leads to a higher density and better organization of death receptors on the cell surface, facilitating stronger immune synapse formation and improved tumor cell eradication.
The Science Behind Our Approach
Our technology leverages small molecules to modulate cell membrane mechanics, targeting key pathways that influence receptor clustering and immune response. By focusing on tumor-cell membrane tension, we aim to overcome common mechanisms of immune escape, making immunotherapies more effective against resistant solid tumors.
Advancing Cancer Treatment
OncoMechanics is committed to developing a versatile 'booster' that can be seamlessly integrated with existing immunotherapies. Our approach does not require engineering new immune-cell products, offering a cost-effective and efficient solution to enhance cancer treatment outcomes.
Modality Overview
Our innovative small molecule combination therapy is designed to enhance the efficacy of existing immunotherapies. By utilizing a platform technology, we focus on modulating cell membrane tension to make tumor cells more susceptible to immune attack. This approach leverages various chemical pathways, including cytoskeletal and contractility modulators, as well as membrane-lipid and cholesterol modifiers, to optimize treatment outcomes.
Target Mechanism
Understanding Our Target
The primary target of our therapy is the mechanical properties of tumor-cell membranes. By increasing membrane tension and stiffness, we aim to enhance the organization and density of death receptors on the cell surface. This biophysical manipulation is crucial for improving immune synapse formation and facilitating effective immune-mediated apoptosis.
Our focus on tumor-cell membrane mechanics addresses a critical control point in receptor trafficking, which is essential for overcoming immune resistance. By elevating receptor levels above the threshold needed for effective immune activation, we strive to reduce immune escape mechanisms commonly observed in solid tumors.
Join the Fight Against Cancer
Discover how OncoMechanics is pioneering a new frontier in cancer treatment through our unique mechanosensitization strategy. We invite you to explore our innovative approach and learn how we are making strides in improving the effectiveness of immunotherapies. Join us on our mission to transform cancer care and improve patient outcomes.